These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 26506915

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
    Warth A, Muley T, Meister M, Stenzinger A, Thomas M, Schirmacher P, Schnabel PA, Budczies J, Hoffmann H, Weichert W.
    J Clin Oncol; 2012 May 01; 30(13):1438-46. PubMed ID: 22393100
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients.
    Russell PA, Barnett SA, Walkiewicz M, Wainer Z, Conron M, Wright GM, Gooi J, Knight S, Wynne R, Liew D, John T.
    J Thorac Oncol; 2013 Apr 01; 8(4):461-8. PubMed ID: 23486266
    [Abstract] [Full Text] [Related]

  • 10. The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype.
    Kadota K, Yeh YC, Sima CS, Rusch VW, Moreira AL, Adusumilli PS, Travis WD.
    Mod Pathol; 2014 May 01; 27(5):690-700. PubMed ID: 24186133
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients.
    Sun Y, Yu X, Shi X, Hong W, Zhao J, Shi L.
    World J Surg Oncol; 2014 May 19; 12():148. PubMed ID: 24885205
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.
    Eguchi T, Kadota K, Park BJ, Travis WD, Jones DR, Adusumilli PS.
    Semin Thorac Cardiovasc Surg; 2014 May 19; 26(3):210-22. PubMed ID: 25527015
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cytopathology of pulmonary adenocarcinoma with a single histological pattern using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) classification.
    Rodriguez EF, Dacic S, Pantanowitz L, Khalbuss WE, Monaco SE.
    Cancer Cytopathol; 2015 May 19; 123(5):306-17. PubMed ID: 25788465
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations.
    Tsuta K, Kawago M, Inoue E, Yoshida A, Takahashi F, Sakurai H, Watanabe SI, Takeuchi M, Furuta K, Asamura H, Tsuda H.
    Lung Cancer; 2013 Sep 19; 81(3):371-376. PubMed ID: 23891509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.